Labiotech.eu

diabetic foot ulcer wound healing reapplix

News and Trends 17 Jul 2020

Danish Wound Healing Biotech Raises €20M to Accelerate US Rollout

Reapplix, a Danish biotech focusing on developing wound healing technology, has raised €19.8M in equity funding to commercialize a treatment for diabetic foot ulcers in the US. The company also announced it has received Medicare reimbursement instructions that it will receive an average of €1,420 ($1,623) for each patient in the US that receives its […]

July 17, 2020 - 3 minutesmins - By Helen Albert

News and Trends 16 Jul 2020

European Biotech Stocks Shine Amid 2020 Market Slump

As the Covid-19 pandemic leads us to the worst financial crisis in decades, normally volatile biotech stocks are outperforming most other sectors of the economy. Experts say this trend is likely to continue. Financial markets are in flux and according to a recent study by the Boston Consulting Group, the global economic slump caused by […]

July 16, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 14 Jul 2020

Amryt Makes Nasdaq Debut to Fund Rare Disease Treatments

UK-based biopharmaceutical Amryt Pharma has listed on the Nasdaq Stock Market in a move to increase its US presence as it commercializes treatments for rare diseases such as the skin condition epidermolysis bullosa. The company did not raise any extra capital by releasing new shares in this debut, as is typical for most listings. But it […]

July 14, 2020 - 3 minutesmins - By Victor Kotsev

varmx blood thinners clot eartern brown snake

News and Trends 14 Jul 2020

€32M Series B to Fund Bleeding Medication Inspired by Snake Venom

The Dutch biotech VarmX will use the proceedings of a €32M Series B to take a blood clotting protein drug into clinical trials by 2021, as well as strengthening its manufacturing and R&D capabilities. More than 10 million patients in the US and Europe at risk of blood clots and strokes receive blood thinners that […]

July 14, 2020 - 2 minutesmins - By Kostas Vavitsas

News and Trends 13 Jul 2020

Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal

The Dutch biotech Kiadis Pharma has licensed an off-the-shelf cell therapy program to the pharma giant Sanofi for up to €857.5M in a deal aiming to develop a combination immunotherapy for the blood cancer multiple myeloma. The preclinical-stage cell therapy that Kiadis licensed is based on genetically modifying donor immune cells called natural killer cells, […]

July 13, 2020 - 3 minutesmins - By David Wilson

News and Trends 13 Jul 2020

Forbion Raises €185M to Fuel Late-Stage European Biotechs

The Dutch life sciences venture capital firm Forbion has bagged €185M in the first closing of a fund aimed at investing in late-stage European biotech companies, which often struggle to raise capital. The main mission of Forbion’s fund — named the Growth Opportunities Fund — is to invest in European life sciences companies raising their […]

July 13, 2020 - 3 minutesmins - By David Wilson

In Depth 13 Jul 2020

The Three Obstacles Stopping Cell Therapy Becoming Mainstream

While there are now more cell therapies on offer than ever before, there are obstacles still preventing them from becoming widely used. Cell therapy holds enormous promise for treating many different diseases. However, the field has also seen controversy regarding therapies using embryonic stem cells, as well as problematic fraud cases. Some forms of cell […]

July 13, 2020 - 9 minutesmins - By Helen Albert

News and Trends 10 Jul 2020

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

Stockholm and Copenhagen-based Eir Ventures has announced the closure of its first fund at €76M, which will be used to invest in biotechs and other life science companies, with a focus on the Nordics. The fund is backed by Saminvest, a venture capital company founded by the Swedish Government; Vækstfonden, the Danish state’s investment fund; […]

July 10, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 9 Jul 2020

€18M to Fund First-in-Class Systemic Sclerosis Drug

One of the largest biotech placements in the Nordic countries this year will accelerate the development of a first-in-class drug for chronic inflammation conditions such as systemic sclerosis that lacks the cardiovascular risks of current medications such as aspirin. Swedish biotech Gesynta Pharma raised €18.2M (SEK 190M) in a placement supported by returning investor Industrifonden […]

July 9, 2020 - 2 minutesmins - By Victor Kotsev

News and Trends 8 Jul 2020

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines

Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from Bpifrance. The funding will be used to develop vaccines that protect from all current – and even future – flu and coronavirus outbreaks. Most current vaccines have a specific target protein they work against. They train the immune system to […]

July 8, 2020 - 3 minutesmins - By Kostas Vavitsas

News and Trends 8 Jul 2020

Remdesivir Becomes the First Covid-19 Treatment Approved in Europe

Remdesivir has received a one-year conditional marketing authorization from the European Commission due to the urgency of the Covid-19 pandemic, which has infected at least 2.5 million people in Europe, and killed more than 500,000. The intravenous drug, manufactured by US pharma company Gilead Sciences, is intended for adults and children over the age of […]

July 8, 2020 - 3 minutesmins - By Victor Kotsev

News and Trends 7 Jul 2020

UK Launches Clinical Trial Platform to Speed up Covid-19 Drug Development

Researchers in the UK have set up a drug testing platform to bridge the gap between preclinical testing and large-scale trials for drugs being tested to treat Covid-19. The AGILE platform is a collaboration between the University of Liverpool, the Liverpool School of Tropical Medicine, and the Southampton Clinical Trials Unit that aims to speed […]

July 7, 2020 - 3 minutesmins - By Helen Albert

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Danish Wound Healing Biotech Raises €20M to Accelerate US Rollout

European Biotech Stocks Shine Amid 2020 Market Slump

Amryt Makes Nasdaq Debut to Fund Rare Disease Treatments

€32M Series B to Fund Bleeding Medication Inspired by Snake Venom

Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal

Forbion Raises €185M to Fuel Late-Stage European Biotechs

The Three Obstacles Stopping Cell Therapy Becoming Mainstream

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

€18M to Fund First-in-Class Systemic Sclerosis Drug

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines

Remdesivir Becomes the First Covid-19 Treatment Approved in Europe

UK Launches Clinical Trial Platform to Speed up Covid-19 Drug Development

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!